We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms
The overarching goal of the Post-traumatic Stress Disorder / Traumatic Brain Injury (PTSD / TBI) Clinical Consortium is to combine efforts of the nation''s leading Investigators to bring to the market novel treatments or interventions that will ultimately decrease the impact of military-relevant psychological health problems and TBI. Working together we hope to improve the function, wellness, and overall quality of life for Service members, as well as their families, caregivers, and the American public. Our vision is to design and conduct a series of innovative coordinated clinical trials that are characterized by: * Scientific excellence * State-of-the-art methodology in prevention, detection and treatment * Advanced translational research that will inform future therapies * Dignity and respect for all stakeholders Funding Trials Coming Soon: We anticipate about 10 trials of novel approaches for the treatment of PTSD, TBI, and their combination. Current Trials: * A PILOT SAFETY and FEASABILITY STUDY of HIGH DOSE LEFT PREFRONTAL TRANSCRANIAL MAGNETIC STIMULATION (TMS) to RAPIDLY STABILIZE SUICIDAL PATIENTS with PTSD or TBI, or BOTH. * THE EFFECT of TELEPHONE FOLLOW-UP on OUTCOME for SERVICE MEMBERS with MILD TBI / PTSD * A PROOF-OF-CONCEPT, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLLED STUDY of GANAXOLONE in POSTTRAUMATIC STRESS DISORDER
A permutation-based method (written in Python) for ascertaining genes with a somatic mutation distribution showing evidence of positive selection for non-silent mutations.
CTSpedia is a national effort to collect wisdom, tools, educational materials, and other items useful for clinical and translational researchers and to provide timely and useful advice to clinical and translational researchers with specific problems. The CTSpedia is a collaborative vehicle for the CTSA''s Biostatistics/Epidemiology/Research/Design (BERD) Online Resources and Education taskforce to identify and share resources across the national consortium and community researchers world-wide. With the support of the national BERD consortia, the project obtained funding and support from the National Center for Research Resources (NCRR) to expand the original scope and content of CTSpedia and foster collaboration amongst CTSAs. The main goal of CTSpedia.org is to create a definable academic home on the internet for the discipline of clinical and translational sciences across the country and the world. * While the CTSA consortium serves the onsite physical level of the institutions involved, CTSpedia.org seeks to fill the gaps where the network is lacking, and to augment that network as the central hub for the peer to peer sharing of knowledge and resources. * While the CTSA national scope comes to fruition, the international scope of the consortia is more readily facilitated with an online resource like CTSpedia. * Utilizing the collaborative nature of the wiki-style website, CTSpedia.org allows for researchers anywhere in the world to ask questions and receive answers and related information in a timely and efficient manner, overcoming the logistical issues of distance and scheduling. * The streamlined availability of an online resource and knowledge repository will aid in addressing common issues that arise in clinical research, which will filter out consultation requests for minor questions, allowing for CTSA consultants to address more prevalent consultations.
A cross-national data archive located in Luxembourg that contains two primary databases: the Luxembourg Income Study Database (LIS Database) includes income microdata from a large number of countries at multiple points in time. The newer Luxembourg Wealth Study Database(LWS Database) includes wealth microdata from a smaller selection of countries. Both databases include labor market and demographic data as well. Our mission is to enable, facilitate, promote, and conduct cross-national comparative research on socio-economic outcomes and on the institutional factors that shape those outcomes. Since its beginning in 1983, the LIS has grown into a cooperative research project with a membership that includes countries in Europe, North America, and Australia. The database now contains information for more than 30 countries with datasets that span up to three decades. The LIS databank has a total of over 140 datasets covering the period 1968 to 2005. The primary objectives of the LIS are as follows: * Test the feasibility for creating a database containing social and economic data collected in household surveys from different countries; * Provide a method which allows researchers to use the data under restrictions required by the countries providing the data; * Create a system that allows research requests to be received from and returned to users at remote locations; and * Promote comparative research on the social and economic status of various populations and subgroups in different countries. Data Availability: The dataset is accessed globally via electronic mail networks. Extensive documentation concerning technical aspects of the survey data, variables list, and the social institutions of income provision in member countries are also available to users through the project Website. * Dates of Study: 1968-present * Study Features: International * Sample Size: 30+ Countries Link: * ICPSR: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/00150
THIS RESOURCE IS NO LONGER IN SERVICE, documented September 6, 2016. CarePath was founded for inducing change and delivering evidence based care in America that can lead to better medical outcomes for seriously ill and reduction in cost of care. The initial focus of CarePath is on traumatic brain injury CarePath is now working with several states and many of the leading trauma hospitals on the implementation of evidence-based treatment guidelines on behalf of traumatic brain injured patients in order to dramatically improve patient outcomes and reduce the need for long term care.
H. Lee Moffitt Cancer Center & Research Institute has made a lasting commitment to the prevention and cure of cancer, working tirelessly in the areas of patient care, research and education to advance one step further in fighting this disease. As part of an elite group of National Cancer Institute (NCI) Comprehensive Cancer Centers, Moffitt focuses on the development of early stage translational research aimed at the rapid translation of scientific discoveries to benefit patient care. Since the first patient admission in October 1986, Moffitt physicians, scientists and staff members have worked together to establish a tradition of excellence offered in an atmosphere characterized by kindness, caring and hope. The Cancer Center''s future growth in clinical care and research rests firmly on this tradition and makes possible the changes ahead. The mission of Moffitt Cancer Center is to contribute to the prevention and cure of cancer. Moffitt''s vision is to be the leader in scientific discovery and translation into compassionate care, cures, and prevention of cancer for our community and the world. As it grows to fulfill its mission, the Cancer Center will continue to be distinguished by its compassionate and effective patient care. Moffitt Cancer Center is a not-for-profit institution. It includes private patient rooms, the Southeast''s largest Blood and Marrow Transplant Program, outpatient treatment programs that record more than 320,500 visits a year, the Moffitt Research Center, Moffitt Cancer Center at International Plaza and the Lifetime Cancer Screening & Prevention Center.
Established in 2002, Angioma Alliance is a patient-driven, non-profit patient advocacy organization. Our mission is to inform and support individuals affected by cerebral cavernous malformations while facilitating improved diagnosis and management of the illness through education and research. We are dedicated to improving the lives of those affected by cavernous angioma. There are many needs that we have been addressing together. First and foremost, people diagnosed with cavernous angiomas have needed more information and a way to talk to others who have the illness. Physicians are frequently unfamiliar with the disease. Internet information has been scarce and technical, and until Angioma Alliance there had been no active internet forums. Many of us have never known anyone else with the illness. Angioma Alliance''s website, peer support program, patient literature, family conferences, and medical convention exhibits have been providing vital information and opportunities for support to those of us affected by cavernous angioma and to the physicians who care for us. Second, we have needed to increase if the public awareness of cavernous angioma. Third, we have needed a way to connect with the research community. Angioma Alliance can be as active and effective as those who choose to volunteer. If you or a family member or friend is affected by cavernous angioma, please consider joining us in our effort.
THIS RESOURCE IS NO LONGER IN SERVICE, documented on February 07, 2013. A multidisciplinary neuroscience laboratory in which basic and clinical scientists work side by side exploring neural mechanisms and models of mental and cognitive function and of neuropsychiatric illness. Experiments are performed at many levels of inquiry, from basic molecular biology of the gene to clinical examinations of patients. A major area of investigation of this laboratory is the genetic mechanisms implicated in the pathogenesis of schizophrenia and its treatment. The laboratory is organized as a multi-disciplinary team of investigators with a common mission: to identify and fully characterize basic genetic and neurobiological mechanisms of schizophrenia and related cognitive and emotional disorders. The various components of this effort are centered various different units or divisions represented by groups of investigators, at various levels of training and experience, working on related experiments. The Director of the Branch and of the Genes, Cognition and Psychosis Program (GCAP) is Daniel R. Weinberger, M.D. The CBDB is the principle research laboratory in the created (2003) Genes, Cognition, and Psychosis Program (GCAP) of the NIMH. After twelve years of residing on the pastoral grounds of St. Elizabeths Hospital, in Southeast Washington, CBDB moved back to the main NIH campus in Bethesda, Maryland in 1998. While the unique setting of St. Elizabeths is irreplaceable, we have occupied beautiful new laboratories and clinic spaces that were created for us, and we are in the mainstream of NIH life., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025.
A clinical research department that specializes in the study of Alzheimer's disease. The Mayo Clinic Alzheimer's Disease Research Center conducts many types of research studies related to dementia, as well as normal or successful aging. The purpose of the center is to provide care for dementia patients and promote research and education on Alzheimer's Disease and related dementias.
A collection of brain tissue from individuals suffering from schizophrenia, bipolar disorder, depression, anxiety disorders, and substance abuse, as well as healthy individuals. The research mission of the NIMH Brain Bank is to better understand the underlying biological mechanisms and pathways that contribute to schizophrenia and other neuropsychiatric disorders, as well as to study normal human brain development.
The USC Geriatric Studies Center includes the State of California Alzheimer's Research Center of California and the National Institute of Aging funded clinical program of the USC Alzheimer's Disease Research Center. It is staffed by USC faculty and physicians with expertise in Alzheimer's disease and age related memory loss. The Center provides evaluation, diagnosis and treatment recommendations, referral to caregiver services and support groups, and the opportunity to participate in clinical drug trials for memory problems.
Non profit organization and informational portal directed towards patients and families. AFA is an umbrella orgnization uniting over 1600 member organizations to collaborate on education, resources, best practices and advocacy. AFA provides several grant opportunities for AFA's nonprofit member organizations and to individuals in need.
A collection of tissue and related clinical data for breast cancer. The Bank stores three types of information on each case within a secure location in CancerCare Manitoba. This information relates to the tissue, clinical, and follow-up information. Tissue information includes the composition of the tissue, the size and type of tumor. Clinical information includes the patient age, clinical symptoms and the results of clinical tests such as x-rays. Follow-up information includes the type of treatment after surgery and the response to this treatment. The Bank provides an important resource both for breast cancer research at the University of Manitoba and for researchers across Canada and internationally. Researchers are charged to cover the costs of storage and release but no tissue or information is sold. The Bank has supported over 50 research studies on breast cancer across North America and Europe. Information is never released from the Bank with any label that might allow it to be traced to an individual. Information is only released as part of a set of anonymized cases, where each case is labeled by an anonymous tumor bank number and consists of a section of tissue with related information. Researchers can apply to study these cases only through a review process and if they obtain approval for their research project from an institutional ethics review board. If approved, researchers are provided with tissue sections and the related clinical information from a set of typically 100 or more ����??cases����??. These cases are carefully selected from the computer database on the basis of selection criteria such as size and type of tumor that are relevant to the research question under study. During the assessment of each breast biopsy specimen small tissue samples are taken by Pathologists to process and examine under a microscope and these samples are then stored as a ����??clinical archive����??. After all diagnosis has been completed the Bank organizes these tissues and related clinical data into ����??cases����?? for both future research and future clinical purposes and stores these ����??cases����?? in CancerCare Manitoba. All cases are distinguished by a Tumor Bank number but are anonymous due to the absence of any tag that might allow it to be traced to an individual patient.
The main goal of PROCURE is to provide science and humanity with means to help prevent and cure prostate cancer a disease which this year alone will be diagnosed in an estimated 25,500 Canadian men and one which will, on average, take the lives of 85 men every week. PROCURE strives to redefine the boundaries of research and knowledge by: * Initiating an on-going dialogue with the public and healthcare community to provide needed information and support through accessible means such as: ** A comprehensive website in French and English ** Lectures and special events ** Free book on prostate cancer * Funding and structuring over time a bank of biological materials and data on men with prostate cancer as well as those at risk of developing the disease. Such a Biobank, as it is known, will accelerate breakthrough scientific discovery. Join our alliance today by informing yourself and loved ones. Encourage the other men you care about to have an examination. Make a contribution to our cause. Help us keep information on this site up-to-date. In doing so you will become part of the force against prostate cancer!
A biomaterial supply resource which collects and disseminates over 1500 brains and links tissue specimens to patient data. The Brain Endowment Bank distributes brain tissue specimens to scientists worldwide who are investigating neurodegenerative and neuropsychiatric diseases, as well as to scientists involved in ongoing studies on the affects of aging. Its overall objective is to support basic and clinical research activities by providing a systematic method for obtaining detailed pre-mortem clinical information, developing procedures for optimizing brain autopsies, cryopreserving neuropathological specimens, and obtaining neuropathological diagnoses after death.
Software to help selecting up to five oligo probes for each of the DNA sequences you provided for microarray spotting.
Virgin Health Bank was developed to meet the needs of families in the UK who are considering banking their baby''s cord blood stem cells and want the support of an ethically motivated cord blood bank committed to delivering high quality service. We provide an HTA licensed state-of-the-art processing and storage service for parents who would like to store the stem cells from their newborn baby''s umbilical cord blood. * Uniquely we offer you a choice of cord blood banking services; your family can choose from our Family Banking service or our Community Banking service. * We empower UK families to make informed decisions about storing their baby''s cord blood stem cells by providing them with accurate and honest information and do not pressure them into buying our services. * Stem cells from our cord blood bank have been used for transplantation by Doctors in the UK''s National Health Service and we''re proud to operate under a license issued to us by the Human Tissue Authority. If you choose our Family Banking service or our Community Banking you will be informed once your baby''s stem cells have been safely collected, tested and stored. If you have chosen our Community Banking service then we will separate the unit into two elements. Your family''s portion of the unit will be treated in exactly the same way as those in our Family Banking service. It is your family''s and nothing will be done to it or with it without your express written permission. We will test the cells to determine the HLA type. Information on the element of the stem cell unit that you have chosen to donate to the community will be included on an international registry alongside those of others. The registry provides real hope to families and individuals afflicted with diseases where cord blood stems cells are approved for treatment. Doctors use this registry as a resource from which they can request donated cord blood for treatments. These are used in circumstances where a tissue typed, donated unit is required rather than the patient''s own. By contributing to the development of this international registry you maximize the availability of stem cells for the treatment of your family and others. By helping others you also help yourself by helping to develop a community stem cell bank from which your own family may benefit.
Not yet vetted by NIF curator
THIS RESOURCE IS NO LONGER IN SERVICE, documented September 6, 2016.
Not yet vetted by NIF curator